The rising interest in potent weight management has led to considerable research into groundbreaking treatments. Currently, Retatrutide, a combined -action glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist , has shown positive results in patient trials, suggesting pote